Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Oculus Launches Wound Treatment Product in ChinaChinaBio Today • Sun, Sep 14, 2008
-
Oculus Receives SFDA Approval for Wound TreatmentChinaBio Today • Tue, Apr 1, 2008
-
Oculus Innovative Sciences IPO Analysis: Six Month ReviewPharmaTracker • Mon, Aug 13, 2007
-
IPO Watch: Oculus Seeks Foothold In Wound HealingCentient Biotech Investor • Thu, Jan 25, 2007
-
New Terms for Oculus Innovative Sciences IPOSA Editor Abbi Adest • Sun, Jan 14, 2007
-
China Biotech In Review: Deals, Trials And RegulationsChinaBio Today • Sun, Jul 15, 2012
-
A Look at 5 Stocks in the Green WednesdayAlex Shadunsky • Thu, Jul 28, 2011
-
China Biotech Week in Review: CROs ConsolidatingChinaBio Today • Sun, Nov 22, 2009
-
Oculus Wins China Approval for Animal Wound ProductChinaBio Today • Tue, Nov 17, 2009
-
China Biopharma Week in Review: Broad Views, Individual CompaniesChinaBio Today • Sun, Sep 14, 2008
-
China Biotech in Review: A Week of CollaborationsChinaBio Today • Sun, Jun 29, 2008
-
Oculus to Use Bayer for Approval of Wound Treatment in AnimalsChinaBio Today • Wed, Jun 25, 2008
-
Following the China Biopharma BeatChinaBio Today • Sun, May 25, 2008
-
Downturn in China Biotech Stocks Shows No Impact on ActivityChinaBio Today • Mon, Apr 7, 2008
-
GlobeNewswire (Thu, 4:05PM)
-
GlobeNewswire (Jun 6, 2013)
-
GlobeNewswire (May 23, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 28, 2013)
-
GlobeNewswire (Mar 26, 2013)
-
GlobeNewswire (Mar 20, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
GlobeNewswire (Mar 7, 2013)
-
at MarketWatch.com (Mar 7, 2013)
-
GlobeNewswire (Feb 13, 2013)
OCLS vs. ETF Alternatives
Company Description
Currently, there's no company description for OCLS.



